metoprolol alvogen (metoprolin) tafla 50 mg
alvogen ehf. - metoprololum tartrat - tafla - 50 mg
metoprololsuccinat hexal forðatafla 100 mg
hexal a/s - metoprololum súkkínat - forðatafla - 100 mg
metoprololsuccinat hexal forðatafla 25 mg
hexal a/s - metoprololum súkkínat - forðatafla - 25 mg
metoprololsuccinat hexal forðatafla 50 mg
hexal a/s - metoprololum súkkínat - forðatafla - 50 mg
xtandi
astellas pharma europe b.v. - enzalutamíð - blöðruhálskirtli - innkirtla meðferð - xtandi is indicated for:the treatment of adult men with metastatic hormone-sensitive prostate cancer (mhspc) in combination with androgen deprivation therapy (see section 5. the treatment of adult men with high-risk non-metastatic castration-resistant prostate cancer (crpc) (see section 5. the treatment of adult men with metastatic crpc who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. the treatment of adult men with metastatic crpc whose disease has progressed on or after docetaxel therapy.
veltassa
vifor fresenius medical care renal pharma france - kalsíumhýdrat sorbítak - blóðkalíumlækkun - lyf til meðferð kalíum og blóðfosfathækkun - veltassa er ætlað til meðferðar við blóðkalíumhækkun hjá fullorðnum.
namuscla
lupin europe gmbh - mexiletine hydrochloride - myotonic kvilla - hjarta meðferð - namuscla er ætlað fyrir einkennum meðferð vöðvaherping í fullorðinn sjúklinga með ekki-dystrophic myotonic kvilla.
anatera stungulyf, lausn 10 %
alcon nordic a/s - fluoresceinum natríum - stungulyf, lausn - 10 %
sativex munnholsúði, lausn 27 mg/ml + 25 mg/ml
jazz pharmaceuticals ireland ltd - delta-9-tetrahydrocannabinolum; cannabidiolum inn - munnholsúði, lausn - 27 mg/ml + 25 mg/ml